---All---
  • ---All---
  • Accession
  • Catalog #

RELA Antibody (monoclonal) (M01)Purified Mouse Monoclonal Antibody (Mab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AT3616a 50 ug 400 ul 7-10 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

RELA Antibody (monoclonal) (M01) - Product info

ApplicationIF, WB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ04206
Other AccessionNP_068810
ReactivityHuman
Concentration0.5 mg/ml
IsotypeIgG1 Lambda
Clone Names8G3
Calculated MW60219 Da

RELA Antibody (monoclonal) (M01) - Additional info

Gene ID 5970
Other Names
MGC131774, NFKB3v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian)
Target/Specificity
RELA (NP_068810, 432 a.a. ~ 506 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Dilution
WB~~1:500~1000
Format
Clear, colorless solution in phosphate buffered saline, pH 7.2 .
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
RELA Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.

RELA Antibody (monoclonal) (M01) - Related products

AP3176a: Phospho-NFKBp65-S536 Antibody

AP3178a: Phospho-NFKB-S536 Antibody

AP3717a: Phospho-NF kappa B-S276 Antibody

AP3749a: Phospho-NF kappa B-S536 Antibody

AP6826a: RELA Antibody (N-term)

AP6826c: RELA Antibody (Center)

AP9455a: NF kappa B-S276

RI14507: RELA predesign siRNA

DC03759: Human RELA cDNA Clone

LY10116a: RELA Over-expression Lysate

BP3176a: Phospho-NFKBp65-S536 Antibody Blocking Peptide

BP3178a: Phospho-NFKB-pS536 Antibody Blocking Peptide

BP3717a: Phospho-NF kappa B-S276 Antibody Blocking Peptide

BP6826a: RELA Antibody (N-term) Blocking Peptide

BP6826c: RELA Antibody (Center) Blocking Peptide

BP9125c: NF kappa B-S276 Antibody Blocking Peptide

BP9455a: NF kappa B-S276 Blocking Peptide

AT3616a: RELA Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

NFKB1 (MIM 164011) or NFKB2 (MIM 164012) is bound to REL (MIM 164910), RELA, or RELB (MIM 604758) to form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA, MIM 164008 or NFKBIB, MIM 604495), which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA, MIM 600664, or IKBKB, MIM 603258) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine).

REFERENCES

Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Bailey SD, et al. Diabetes Care, 2010 Jul 13. PMID 20628086.Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Zhang HN, et al. Biochem Biophys Res Commun, 2010 Jul 2. PMID 20617556.Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering. Tromp JM, et al. Oncogene, 2010 Sep 9. PMID 20581863.Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Annunziata CM, et al. Cancer, 2010 Jul 1. PMID 20564628.Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. Jutooru I, et al. J Biol Chem, 2010 Aug 13. PMID 20538607.